Switch View
© Globe Newswire
03.11.2025
ISIN: US1420381089
Caribou Biosciences Inc
CRBU
LISTED
NASDAQ
Caribou Biosciences to Participate in Upcoming Investor Conferences
News Preview
BERKELEY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference
News Preview
SECAUCUS, N.J., Nov. 3, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends duri...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US0067391062
Addus Homecare Corp
ADUS
LISTED
NASDAQ
Addus HomeCare Announces Third Quarter 2025 Financial Results
News Preview
Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025.
Third Quarter 2025 Highlights:
Net Service Revenues Grow 25.0% to $362.3 Million
Net Income of $22.8 Million, or $1.24 per Diluted Share
Adjusted Net Income pe...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
03.11.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AMONDYS 45 (casimersen) and VYONDYS 53 (golo...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
03.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Participation in Upcoming Investor Healthcare Conferences
News Preview
Savara Inc. (Nasdaq: SVRA) (the “Company”), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1x1 meetings and participate in fireside chats at two upcoming healthcare conferences.
Fireside Chats:
Guggenheim 2nd Annual Healthcare Innovation Conference
Novem...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended September 30, 2025, and provided a business update.
“We are thrilled that 204 new patients have received IBTROZI during our first full quarter as a commerc...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
News Preview
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com.
“This quarter we continued to prove that our vision of helping tens of millions of...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US6047491013
Mirum Pharmaceuticals Inc
TKOMF
LISTED
OTC
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences:
2025 Stifel Healthcare Conference
Company p...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences Announces Third Quarter 2025 Results
News Preview
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for the third quarter ended September 30, 2025, compared to $709 million for the same period of 2024.
“Exact Sciences continues to advance our mission to prevent cancer and detect it...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US62857J2015
Myomo, Inc.
MYO
LISTED
XASE
Myomo to Report Third Quarter 2025 Financial Results on November 10
News Preview
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025. Management will hold a confe...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US48576U2050
Karyopharm Therapeutics Inc
KPTI
LISTED
NASDAQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEWTON, Mass., Nov. 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 800 restricted stock units (RSUs) to one newly-hired employee. This RSU award was granted a...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US83444M1018
Solventum Corporation
SOLV
LISTED
NYSE
Solventum to Participate in the 2025 Stifel Healthcare Conference
News Preview
ST. PAUL, Minn., Nov. 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, Nov. 12, 2025, beginning at approximately 11:20 a.m. EST in New York, NY....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
03.11.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results
News Preview
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor web...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex Reports Third Quarter 2025 Financial Results
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2025, and refined full year 2025 financial guidance.
“Vertex delivered strong results across the board in the third quarter, extending our leadership in CF, continuing to build global momentum for CASGEVY, an...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Opens 2026 Annual Research Program to Advance Orthodontic and Dental Patient Care
News Preview
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2026 Annual Research Award Program to support c...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US4364401012
Hologic Inc
HOLX
LISTED
NASDAQ
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 27, 2025. The Company reported revenue of $1,049.5 million, GAAP diluted EPS of $0.83, and non-GAAP diluted EPS of $1.13.
Highlights
On October 21, 2025, the Company announced it had entered into a definitive agreement to...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grant
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 90,750 common...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US40637H1095
Halozyme Therapeutics Inc
HALO
LISTED
NASDAQ
HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
News Preview
Royalty Revenue Increased 52% YOY to Record $236 million and Total Revenue Increased 22% YOY to Record $354 million
Net Income Increased 28% YOY to $175 million; Adjusted EBITDA Increased 35% YOY to $248 million; GAAP Diluted EPS Increased 36% YOY to $1.43; Non-...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US98160J1088
MariMed Inc.
MRMD
LISTED
CSE
MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers
News Preview
MariMed to distribute hemp THC versions of core brands, beginning with Vibations drink mix....
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
News Preview
Approved indication: KYGEVVI® (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years.1
Survi...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
News Preview
― Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US80303D3052
SANUWAVE Health, Inc.
SNWV
LISTED
NASDAQ
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
News Preview
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
News Preview
Chatillion, France, November 3, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US68062P1066
Olema Pharmaceuticals, Inc.
OLMA
LISTED
NASDAQ
Olema Oncology to Participate in Upcoming Investor Conferences
News Preview
Olema Oncology to Participate in Upcoming Investor Conferences...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
News Preview
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US9026731029
UFP Technologies Inc
UFPT
LISTED
NASDAQ
UFP Technologies Announces Strong Q3 2025 Results
News Preview
NEWBURYPORT, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $16.4 million or $2.11 per diluted common share outstanding for its third quarter ended September 30, 202...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US08659B1026
Beta Bionics, Inc.
BBNX
LISTED
NASDAQ
Beta Bionics Announces Participation at Upcoming Investor Conferences
News Preview
IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time):...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US29358P1012
Ensign Group Inc
ENSG
LISTED
NASDAQ
The Ensign Group Reports Third Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
News Preview
Conference Call and Webcast scheduled for tomorrow, November 4, 2025 at 10:00 am PT Conference Call and Webcast scheduled for tomorrow, November 4, 2025 at 10:00 am PT...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
Castle Biosciences Reports Third Quarter 2025 Results
News Preview
Castle Biosciences, Inc. (Nasdaq: CSTL) today announced its financial results for the third quarter and nine months ended Sept. 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
News Preview
Nyxoah to Participate in the Stifel 2025 Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
News Preview
Myriad Genetics today announced financial results for its third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US45784A1043
InnovAge Holding Corp
INNV
LISTED
NASDAQ
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
News Preview
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Announces Investor Conference Presentations
News Preview
TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US7473241013
Pyxis Oncology Inc
PYXS
LISTED
NASDAQ
Pyxis Oncology to Participate in Upcoming Investor Conferences
News Preview
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will participate in the following upcoming investor conferences in November 2025:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US87357P1003
Tactile Systems Technology Inc
TCMD
LISTED
NASDAQ
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
News Preview
MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2025 and announced the adoption of a second share repurcha...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook
News Preview
MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 3...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix Announces Third Quarter 2025 Results and Highlights
News Preview
Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024;...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Securities Fraud Investigation Into Avantor, Inc. (AVTR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVANTOR, INC....
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US70975L1070
Penumbra Inc
PEN
LISTED
NYSE
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
News Preview
The STORM-PE RCT data presented at the VIVA 2025 Conference showed PE patients treated with CAVT in combination with anticoagulation demonstrated significantly greater improvements in thrombus burden reduction, heart rate, oxygen requirement, and functional outcomes compared to those who rece...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Magnolia Health Offers Health Insurance in Mississippi in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Magnolia Health plans statewide.
JACKSON, Miss., Nov. 3, 2025 /PRNewswire/ -- Ambetter from Magnolia Health, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthca...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
News Preview
Tevogen clarifies GAAP-reported deficit, citing strong capital efficiency, low cash burn, and plans to share reconciled non-GAAP metrics....
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: IT0003828271
Recordati Industria Chimica e Farmaceutica SpA
REC
LISTED
EURONEXT
Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
News Preview
Poster presentations at ASH highlight advances in the understanding and research of Castleman disease, cold agglutinin disease, B-cell lymphoma, and other hematologic conditions
BRIDGEWATER, N.J., Nov. 3, 2025 /PRNewswire/ -- Recordati Rare Diseases Inc. today a...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor, Inc. (AVTR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AVANTOR, INC. (AVTR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US82835W1080
ARS Pharmaceuticals Inc
SBTX
LISTED
NASDAQ
UPDATE -- ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
News Preview
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray)...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclos...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
Organogenesis Applauds CMS’s Significant Step In Payment Reform
News Preview
With evidence-based portfolio including technologies in each FDA category, we believe we are best positioned in the skin substitutes market for 2026 and beyond With evidence-based portfolio including technologies in each FDA category, we believe we are best positioned in the skin substitutes market for 2026 and beyond...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
News Preview
Leuven, BELGIUM, November 3, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, announces the termination of discussions regarding the planned acquisition of a company specialized in preclinical microbiology services (see press release dated June 19, 2025 – link). Following a thor...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion met fin aux discussions relatives à une transaction ciblée en préclinique annoncée précédemment et poursuit l'intégration d'un acteur clinique stratégique
News Preview
Louvain, BELGIQUE – 3 novembre 2025 – 18h00 – Oxurion NV (Euronext Bruxelles : OXUR), société de sous-traitance pharmaceutique basée à Louvain, annonce la fin des discussions relatives à l'acquisition projetée d'une société spécialisée dans les services...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion beëindigt gesprekken over eerder aangekondigde preklinische overname en zet integratie voort van een strategische klinische speler
News Preview
Leuven, BELGIË, 3 november 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, maakt bekend dat het de gesprekken heeft beëindigd met betrekking tot de overwogene overname van een vennootschap gespecialiseerd in preklinische microbiologische diensten (zie persbericht...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera Issues Statement in Response to Litigation
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer:
"Pfizer is trying to litigate its way to buying Metsera for a lower price than Nov...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions
composant le capital...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter Health Offers Health Insurance in Iowa in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable
Ambetter Health plans in 58 counties
DES MOINES, Iowa, Nov. 3, 2025/PRNewswire/ -- Ambetter Health, a product...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner
James (Josh) Wilson
Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Cytokinetics betwee...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Baxter To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 in Baxter between February...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US52490G1022
Legend Biotech Corp
LEGN
LISTED
NASDAQ
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
News Preview
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
News Preview
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four presentations at the 67th Annual American Society of Hematology (ASH) Annual Meet...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MLTX To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MoonLake To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in MoonLake between March...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Health Net Offers Health Insurance in California in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Health Net plans in 10 counties
SACRAMENTO, Calif., Nov. 3, 2025 /PRNewswire/ -- Ambetter from Health Net, a product offered by Health Net of California (Health Net), a subsidiary of Centene C...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
